Foreign Clinical Studies Not Conducted Under an IND

Forms and Documents

Document	Type	Status	Availability
0622 SUPPORTING STATEMENT FINAL 6-10-13.doc	Supporting Statement A	Uploaded 2013-06-14	Available

IC Document Collections

IC ID	Collection	Type	Status	Form
184501	Foreign Clinical Studies Not Conducted Under an IND - 312.120		Modified

ICR Details

OMB Control No: 0910-0622	ICR Reference No: 201306-0910-008
Status: Historical Active	Previous ICR Reference No: 200804-0910-001
Agency/Subagency: HHS/FDA	Agency Tracking No: 19758
Title: Foreign Clinical Studies Not Conducted Under an IND
Type of Information Collection: Existing collection in use without an OMB Control Number	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 08/16/2013
	Date Received in OIRA: 06/14/2013
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	08/31/2016	36 Months From Approved
Responses	1,185	0	0
Time Burden (Hours)	37,920	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: Under Section 312.120, sponsors submit foreign clinical studies not conducted under an Investigational New Drug as support for an IND or application for marketing approval for a drug or biological product. The studies must be conducted in accordance with Good Clinical Practice, including review and approval by an independent ethics committee.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	78 FR 13067	02/26/2013
30-day Notice:	Federal Register Citation:	Citation Date:
	78 FR 33847	06/05/2013
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Foreign Clinical Studies Not Conducted Under an IND - 312.120

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	1,185	0	0	0	1,185	0
Annual Time Burden (Hours)	37,920	0	0	0	37,920	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The burden estimates preapproved by the Office of Management and Budget in the April 28, 2008 final rule have been updated by FDA's Economics Staff to reflect current burdens.

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? Yes

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 06/14/2013

---